Brighter
Healthcare Software · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Borgarfjordsgatan 18, Kista, Stockholm, ...Phone Number
+46 855008820Website
www.brighter.seRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones, and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brighter your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Brighter has new funding data
Product Launch: Get notified when Brighter launches new products
Check if Brighter has recently received funding, and reach out quickly before it becomes old news!
Brighter, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Brighter is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Brighter
Click to see if Brighter had a recent Job posting/layoffs
Earning: See what the market has to say on Brighter recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Brighter is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Brighter is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Brighter.
Brighter financials insights
Gather financial insights about Brighter, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$1.3M
Brighter Tech Stack
A closer look at the technologies used by Brighter
See more technologies
Most Recent Scoops
Pain Point
Bankruptcy
Left Company
Executive Move
Brighter has announced that Christopher Robinson has stepped down from the role of Chief Financial Officer.
New Hire
Executive Move
Brighter has announced that Malin Hollander has joined the organization as Interim Chief Financial Officer. Previously, Hollander served as Chief Operating Officer for KRY.
Promotion
Executive Move
Promotion
Executive Move
Brighter News & Media
Brighter files for bankruptcy
Brighter AB (Publ.) (“The Company”) In light of the district court's decision on November 21, 2022 that the corporate restructuring must cease, the board of Brighter AB has decided that the company will file for bankruptcy. The application has been sent to Solna District Court. During the past 1.5 years, the new board and management have worked intensively to activate a long-term business strategy to create profitable growth, but the work has been characterized byBrighter postpones publication of Q3 report
Brighter AB (Publ.) (“Brighter” or the “Company”) announces today that publication of the quarterly report for Q3 2022 has been postponed from November 23 to November 29. The reason is that Brighter's board needs more time to evaluate the situation after the district court's decision that the company's corporate restructuring must end. With the district court's decision, Brighter's board needs more time to evaluate the situation, continue working on ongoing discussions and thus be ableDecision from Nasdaq Stockholm's disciplinary board imposes a fine on Brighter of 8 annual fees corresponding to approx. 1,5 MSEK
Brighter AB (publ.) (“Brighter” or “the company”) announced today that Nasdaq Stockholm's disciplinary committee has decided to impose a fine on Brighter as a result of the company's handling of information on different occasions since 2020. The stock exchange has claimed that Brighter violated the Regulations by not publishing insider information in the correct way and by holding the general meeting too late. For more information, please contact: Investor Relations IR@brighter.se Certified AdviThe district court decides that Brighter's corporate restructuring must end
Since November 2, 2022, Brighter AB (Publ.) (“the Company”) has been in corporate restructuring with the aim of giving the Company time to negotiate a long-term financial solution and implement operational and organizational changes for profitable growth. The district court has today decided that the reconstruction must cease immediately and the board of Brighter AB will now evaluate the situation. Overall, the district court assesses that Brighter AB - in light of discussions and presentations
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Brighter
Sign Up For FreeTo access detailed company insights
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease p... Read More
